MA Boston의 암 (전체) 임상 시험
암 (전체) 관련 연구 86개가 Boston 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
A Study of ASP3082 in Adults With Advanced Solid Tumors
피험자 모집 중1상
- Beth Israel Deaconess Medical Center, Boston
- Dana Farber Cancer Institute, Boston
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
피험자 모집 중1상
- Beth Israel Deaconess Medical Center - Research, Boston
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
피험자 모집 중1상
- Massachusetts General Hospital, Boston
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
피험자 모집 중관찰 연구
- Mass General Brigham, Boston
- Brigham and Women's Hospital, Boston
A Study of PHN-012 in Patients With Advanced Solid Tumors
피험자 모집 중1상
- PHN-012-001 Site, Boston
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
피험자 모집 중3상
- Investigative Site, Boston
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
피험자 모집 중1/2상
- Dana Farber Cancer Center ( Site 4013), Boston
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
피험자 모집 중3상
- Dana Farber/Harvard Cancer Center, Boston
Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease
피험자 모집 중
- Massachusetts General Hospital, Boston
Pan Tumor Rollover Study
피험자 모집 중2상
- Dana_Farber Cancer Institute (DFCI), Boston
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
피험자 모집 중3상
- Dana-Farber Cancer Institute /ID# 279690, Boston
Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
피험자 모집 중3상
- Beth Israel Deaconess Medical Center ( Site 0107), Boston
- Dana-Farber Cancer Institute ( Site 0105), Boston
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
피험자 모집 중1/2상
- Dana Farber Cancer Institute, Boston
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
피험자 모집 중2/3상
- Massachusetts General Hospital / Dana-Farber Cancer Institute, Boston
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
피험자 모집 중1/2상
- Dana-Farber Cancer Institute ( Site 3013), Boston
Proof-of-Concept Testing of the Cardiovascular Health Equity Through Food (CHEF) Intervention in Childhood Cancer Survivors
피험자 모집 중
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Statins to Prevent Cancer Associated Blood Clots
피험자 모집 중4상
- Beth Isreal Deaconess Medical Center, Boston
- Dana-Farber Cancer Institute, Boston
ACTIVATE: AI-driven Clinical-trial Trial-Information and Viability Assessment Tool for EHRs
피험자 모집 중
- Dana-Farber Cancer Institute, Boston
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
피험자 모집 중2상
- Dana Farber Cancer Institute, Boston
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
피험자 모집 중2상
- Dana-Farber Cancer Institute, Boston
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
피험자 모집 중1/2상
- Dana-Farber Cancer Institute /ID# 271846, Boston
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
피험자 모집 중1/2상
- Research Site, Boston
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
피험자 모집 중1/2상
- Dana-Farber Cancer Institute, Boston
A Phase 1/1b Study of IAM1363 in HER2 Cancers
피험자 모집 중1상
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
피험자 모집 중3상
- Boston Medical Center, Boston
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
피험자 모집 중관찰 연구
- Dana Farber Cancer Institute, Boston
Lurbinectedin in FET-Fused Tumors
피험자 모집 중1/2상
- Dana-Farber Cancer Institute, Boston
Prostate Active Surveillance Study
피험자 모집 중관찰 연구
- Beth Israel Deaconess Medical Center/Harvard Medical School, Boston
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
피험자 모집 중1상
- Massachusetts General Hospital (MG), Boston
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
피험자 모집 중1상
- Massachusetts General Hospital, Boston
BRIDGE-SIC Efficacy Trial
피험자 모집 중
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
Project: Every Child for Younger Patients With Cancer
피험자 모집 중관찰 연구
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
Abatacept in Immune Checkpoint Inhibitor Myocarditis
피험자 모집 중3상
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
- Boston Medical Center, Boston
- 외 1개
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
피험자 모집 중1/2상
- Massachusetts General Hospital, Boston
FOG-001 in Locally Advanced or Metastatic Solid Tumors
피험자 모집 중1/2상
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
피험자 모집 중1상
- Beth Israel Deaconess Medical Center, Boston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
피험자 모집 중1/2상
- Massachusetts General Hospital Cancer Center, Boston
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
피험자 모집 중1상
- Dana-Farber Cancer Institute, Boston
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
피험자 모집 중2상
- Dana-Farber Cancer Institute, Boston
A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer
피험자 모집 중1상건강한 지원자 환영
- Boston Medical Center, Boston
- Massachusetts General Hospital (MGH), Charlestown · 1마일 거리
Distance-Based Exercise to Preserve Function and Prevent Disability
피험자 모집 중
- Dana-Farber Cancer Institute, Boston
Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated Proteinuria
피험자 모집 중1상
- Brigham and Women's Hospital, Boston
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
피험자 모집 중1/2상
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
피험자 모집 중1상
- Dana-Farber Cancer Institute, Boston
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
피험자 모집 중2상
- Massachusetts General Hospital /ID# 273608, Boston
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
피험자 모집 중1/2상
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
The STOP-MED CTRCD Trial
피험자 모집 중4상
- Brigham and Women's Hospital, Boston
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
피험자 모집 중1/2상
- Dana Farber Cancer Institute, Boston
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
피험자 모집 중1상
- GSK Investigational Site, Boston
- GSK Investigational Site, Boston
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
피험자 모집 중1/2상
- Beth Israel Deaconess Medical Center, Boston
- Dana-Farber Cancer Institute, Boston
Childhood Cancer Survivor Study
피험자 모집 중관찰 연구건강한 지원자 환영
- Dana-Farber Cancer Institute, Boston
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
피험자 모집 중
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
피험자 모집 중1상
- Research Site, Boston
- Research Site, Boston
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
피험자 모집 중1상
- Beth Israel Deaconess Medical Center /ID# 252009, Boston
- Dana-Farber Cancer Institute /ID# 249642, Boston
Multisite Implementation of COMPRENDO
피험자 모집 중건강한 지원자 환영
- Dana Farber Cancer Institute/Boston Children's Hospital, Boston
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
피험자 모집 중1상
- Mass General Brigham Cancer Institute, Boston
- Dana Farber Cancer Institute, Boston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
피험자 모집 중1/2상
- Massachusetts General Hospital,, Boston
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
피험자 모집 중1상
- GSK Investigational Site, Boston
Video Inspired Discussions About Ethical Outcomes in Pediatrics
피험자 모집 중
- Dana Farber Cancer Institute, Boston
On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety
피험자 모집 중참여자 보상 언급
- Dana Farber Cancer Institute, Boston
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
피험자 모집 중1/2상
- Massachusetts General Hospital, Boston
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
피험자 모집 중2상
- Dana Farber Cancer Institute, Boston
Intraoperative Tumor Margin Identification With ICG Dye Imaging
피험자 모집 중2상
- Massachusetts General Hospital, Boston
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
피험자 모집 중1/2상
- Dana Farber Cancer Institute, Boston
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
피험자 모집 중1상
- Massachusetts General Hospital, Boston
Suprachoroidal Administration in Subjects With Metastases to the Choroid
피험자 모집 중2상
- Massachusetts Eye and Ear, Boston
Supportive Care Intervention for Outpatient Stem Cell Transplant Patients
피험자 모집 중
- Dana-Farber Cancer Institute, Boston
Positron Emission Tomography (PET) Imaging of Thrombosis
피험자 모집 중1상건강한 지원자 환영
- Massachusetts General Hospital, Boston
Primary Tumor Research and Outcomes Network
피험자 모집 중관찰 연구
- Massachusetts General Hospital, Boston
Pembrolizumab, Ibrutinib and Rituximab in PCNSL
피험자 모집 중1/2상
- Dana Farber Cancer Institute, Boston
- Beth Israel Deaconess Medical Center, Boston
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
피험자 모집 중
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
PediRISE Feasibility
피험자 모집 중
- Boston Children's Hospital, Boston
- Dana Farber Cancer Institute, Boston
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
피험자 모집 중2상
- Dana-Farber Cancer Institute /ID# 230061, Boston
A Dyadic Intervention for Young Adult Patients With Cancer and Their Partner Caregivers
피험자 모집 중
- Massachusetts General Hospital Cancer Center, Boston
A Study of YL242 in Subjects With Advanced Solid Tumors
피험자 모집 중1/2상
- US-204, Boston
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
피험자 모집 중관찰 연구
- Boston Children's Hospital, Boston
Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study
피험자 모집 중건강한 지원자 환영
- Codman Square Health Center, Boston
- East Boston Neighborhood Health Center, East Boston · 2마일 거리
Childhood Cancer Predisposition Study (CCPS)
피험자 모집 중관찰 연구
- Dana Farber Cancer Institute, Boston
BMT-CARE: Psychosocial Intervention for Transplant Caregivers
피험자 모집 중
- Massachusetts General Hospital Cancer Center, Boston
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
피험자 모집 중관찰 연구
- Massachusetts General Hospital, Boston
Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy
피험자 모집 중
- Harvard School of Medicine/Massachusetts General Hospital (MGH), Boston
Evaluating Informatics-assisted Immune-related Adverse Event Detection to Improve Registration Onto a Biorepository
피험자 모집 중1/2상
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Communicating Uncertainties Associated With the Benefits and Risks of New Cancer Drugs
피험자 모집 중건강한 지원자 환영
- Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
피험자 모집 중1/2상
- Massachusetts General Hospital, Boston
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
피험자 모집 중1/2상
- Massachusetts General Hospital, Boston
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
피험자 모집 중3상
- Massachusetts General Hospital, Boston
다른 도시의 암 (전체) 시험
- Houston, TX연구 122개
- New York City, NY연구 110개
- Los Angeles, CA연구 73개
- Nashville, TN연구 65개
- Washington, DC연구 60개
- Philadelphia, PA연구 60개
- Durham, NC연구 59개
- Chicago, IL연구 52개
- Seattle, WA연구 50개
- Atlanta, GA연구 50개
- Arlington, VA연구 48개
- St. Louis, MO연구 47개
Boston의 다른 연구
- 유방암연구 110개
- 비소세포폐암연구 89개
- 대장직장암연구 63개
- 전이성 암연구 63개
- 폐암연구 62개
- 난소암연구 61개
- 전립선암연구 60개
- 우울증연구 51개
- 자궁내막암연구 50개
- 급성 골수성 백혈병연구 45개
- 췌장암연구 44개
- 심부전연구 43개
ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.